The evolving field of biodefence: Therapeutic developments and diagnostics

被引:118
作者
Burnett, JC
Henchal, EA
Schmaljohn, AL
Bavari, S [1 ]
机构
[1] NCI, Dev Therapeut Program, Based Drug Discovery Grp, SAIC, Frederick, MD 21702 USA
[2] USA, Med Res Inst Infect Dis, Frederick, MD 21702 USA
关键词
D O I
10.1038/nrd1694
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The threat of bioterrorism and the potential use of biological weapons against both military and civilian populations has become a major concern for governments around the world. For example, in 2001 anthrax-tainted letters resulted in several deaths, caused widespread public panic and exerted a heavy economic toll. If such a small-scale act of bioterrorism could have such a huge impact, then the effects of a large-scale attack would be catastrophic. This review covers recent progress in developing therapeutic countermeasures against, and diagnostics for, such agents.
引用
收藏
页码:281 / 297
页数:17
相关论文
共 206 条
  • [1] Adler M, 1999, J APPL TOXICOL, V19, pS5, DOI 10.1002/(SICI)1099-1263(199912)19:1+<S5::AID-JAT606>3.0.CO
  • [2] 2-M
  • [3] Efficacy of a novel metalloprotease inhibitor on botulinum neurotoxin B activity
    Adler, M
    Nicholson, JD
    Hackley, BE
    [J]. FEBS LETTERS, 1998, 429 (03) : 234 - 238
  • [4] Molecular mechanisms of filovirus cellular trafficking
    Aman, MJ
    Bosio, CM
    Panchal, RG
    Burnett, JC
    Schmaljohn, A
    Bavari, S
    [J]. MICROBES AND INFECTION, 2003, 5 (07) : 639 - 649
  • [5] Thio-derived disulfides as potent inhibitors of botulinum neurotoxin type B: Implications for zinc interaction
    Anne, C
    Blommaert, A
    Turcaud, S
    Martin, AS
    Meudal, H
    Roques, BP
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (21) : 4655 - 4660
  • [6] Development of potent inhibitors of botulinum neurotoxin type B
    Anne, C
    Turcaud, S
    Quancard, J
    Teffo, F
    Meudal, H
    Fournié-Zaluski, MC
    Roques, BP
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (22) : 4648 - 4656
  • [7] Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation
    Arad, G
    Levy, R
    Hillman, D
    Kaempfer, R
    [J]. NATURE MEDICINE, 2000, 6 (04) : 414 - 421
  • [8] Botulinum toxin as a biological weapon - Medical and public health management
    Arnon, SS
    Schechter, R
    Inglesby, TV
    Henderson, DA
    Bartlett, JG
    Ascher, MS
    Eitzen, E
    Fine, AD
    Hauer, J
    Layton, M
    Lillibridge, S
    Osterholm, MT
    O'Toole, T
    Parker, G
    Perl, TM
    Russell, PK
    Swerdlow, DL
    Tonat, K
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (08): : 1059 - 1070
  • [9] ANTIMICROBIAL SUSCEPTIBILITY TESTING OF FRANCISELLA-TULARENSIS WITH A MODIFIED MUELLER-HINTON BROTH
    BAKER, CN
    HOLLIS, DG
    THORNSBERRY, C
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 22 (02) : 212 - 215
  • [10] The highly specific carbohydrate-binding protein cyanovirin-N: Structure, anti-HIV/Ebola activity and possibilities for therapy
    Barrientos, LG
    Gronenborn, AM
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (01) : 21 - 31